These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15613570)

  • 1. Developmental outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial.
    Schulte J; Osborne J; Benson JW; Cooke R; Drayton M; Murphy J; Rennie J; Speidel B
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F31-5. PubMed ID: 15613570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etamsylate for prevention of periventricular haemorrhage.
    Hunt RW
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F3-5. PubMed ID: 15613569
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
    Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
    Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year follow-up of a randomised trial with repeated antenatal betamethasone.
    Peltoniemi OM; Kari MA; Lano A; Yliherva A; Puosi R; Lehtonen L; Tammela O; Hallman M;
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F402-6. PubMed ID: 19531521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional outcome at school age of preterm infants with periventricular hemorrhagic infarction.
    Roze E; Van Braeckel KN; van der Veere CN; Maathuis CG; Martijn A; Bos AF
    Pediatrics; 2009 Jun; 123(6):1493-500. PubMed ID: 19482759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ethamsylate in preventing periventricular-intraventricular hemorrhage in premature infants below 34 weeks of gestation.
    Sanghvi KP; Merchant RH; Karnik A; Kulkarni A
    Indian Pediatr; 1999 Jul; 36(7):653-8. PubMed ID: 10740301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age.
    O'Shea TM; Washburn LK; Nixon PA; Goldstein DJ
    Pediatrics; 2007 Sep; 120(3):594-602. PubMed ID: 17766533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal phenobarbital therapy and neonatal outcome. II: Neurodevelopmental outcome at 36 months.
    Shankaran S; Woldt E; Nelson J; Bedard M; Delaney-Black V
    Pediatrics; 1996 May; 97(5):649-52. PubMed ID: 8628601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.
    Vohr BR; Poindexter BB; Dusick AM; McKinley LT; Wright LL; Langer JC; Poole WK;
    Pediatrics; 2006 Jul; 118(1):e115-23. PubMed ID: 16818526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and 5-year neurodevelopmental outcomes of very preterm infants: the EPIPAGE cohort study.
    Foix-L'Hélias L; Marret S; Ancel PY; Marchand L; Arnaud C; Fresson J; Picaud JC; Rozé JC; Theret B; Burguet A; Larroque B; Kaminski M;
    BJOG; 2008 Jan; 115(2):275-82. PubMed ID: 18081606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants.
    Bierer R; Peceny MC; Hartenberger CH; Ohls RK
    Pediatrics; 2006 Sep; 118(3):e635-40. PubMed ID: 16908620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
    Fauchère JC; Dame C; Vonthein R; Koller B; Arri S; Wolf M; Bucher HU
    Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
    Marret S; Marpeau L; Follet-Bouhamed C; Cambonie G; Astruc D; Delaporte B; Bruel H; Guillois B; Pinquier D; Zupan-Simunek V; Bénichou J;
    Gynecol Obstet Fertil; 2008 Mar; 36(3):278-88. PubMed ID: 18337147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No change in developmental outcome with incubator covers and nesting for very preterm infants in a randomised controlled trial.
    Maguire CM; Walther FJ; van Zwieten PH; Le Cessie S; Wit JM; Veen S;
    Arch Dis Child Fetal Neonatal Ed; 2009 Mar; 94(2):F92-7. PubMed ID: 18703571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic ethamsylate for periventricular haemorrhage.
    Cooke RW; Morgan ME
    Arch Dis Child; 1984 Jan; 59(1):82-3. PubMed ID: 6696506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre trial of ethamsylate for prevention of periventricular haemorrhage in very low birthweight infants.
    Benson JW; Drayton MR; Hayward C; Murphy JF; Osborne JP; Rennie JM; Schulte JF; Speidel BD; Cooke RW
    Lancet; 1986 Dec; 2(8519):1297-300. PubMed ID: 2878174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antenatal steroids may reduce adverse neurological outcome following chorioamnionitis: neurodevelopmental outcome and chorioamnionitis in premature infants.
    Kent A; Lomas F; Hurrion E; Dahlstrom JE
    J Paediatr Child Health; 2005 Apr; 41(4):186-90. PubMed ID: 15813872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethamsylate in the prevention of periventricular-intraventricular hemorrhage in premature infants.
    Chen JY
    J Formos Med Assoc; 1993 Oct; 92(10):889-93. PubMed ID: 7908570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extreme prematurity: comparison of outcome at 5 years depending on gestational age below or above 26 weeks].
    Autret F; Kieffer F; Tasseau A; Rigourd V; Valleur D; Voyer M; Magny JF
    Arch Pediatr; 2009 Jul; 16(7):976-83. PubMed ID: 19403280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997.
    Mikkola K; Ritari N; Tommiska V; Salokorpi T; Lehtonen L; Tammela O; Pääkkönen L; Olsen P; Korkman M; Fellman V
    Pediatrics; 2005 Dec; 116(6):1391-400. PubMed ID: 16322163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.